Both in Pharmaceuticals
Telomir Pharmaceuticals vs Gossamer Bio
Over the past year TELO returned −37.9% and GOSS returned −94.6%; their daily moves had a correlation of 0.02.
TELO −37.9% GOSS −94.6%Growth of $1, one year, split-adjusted
| Metric | TELO | GOSS |
|---|---|---|
| Price | $0.8750 | $9.95 |
| Market cap | $64.5M | $60.9M |
| Today | −3.85% | +7.22% |
| 1 month | −27.1% | −7.7% |
| 6 months | −34.7% | −64.5% |
| Year to date | −34.2% | −96.0% |
| 1 year | −41.7% | −94.8% |
| Revenue growth (YoY) | — | −19.6% |
| Gross margin | — | 100.0% |
| Net margin | — | 182.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.1× |
| Net cash | $5.0M | $20.9M |
| Dividend yield | — | — |
| Volatility (60d) | 46.6% | 1,266.0% |
| Short % of float | 2.1% | 24.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).